NCT02242240View on ClinicalTrials.gov

Lung Function Changes Following the Addition of Formoterol to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

December 31, 2001

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Formoterol twice daily

DRUG

Formoterol once daily

DRUG

Tiotropium once daily

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY